Department of Internal Medicine, Narendra Modi Medical College, Ahmedabad, Gujarat, India.
Department of Internal Medicine, Crozer Chester Medical Center, Pennsylvania, USA.
Cardiovasc Hematol Agents Med Chem. 2024;22(4):407-412. doi: 10.2174/0118715257267341231031120105.
Obesity and cardiovascular diseases are major health problems worldwide, and weight loss is used as a treatment strategy to enhance various aspects. While there are many weight loss methods, one of the most effective is through a dietary approach. The ketogenic diet (KD), which is characterized by low carbohydrates and high levels of fat and/or protein, is used in obese patients as it is a promising treatment option for weight loss as well as for controlling the risk factors for cardiovascular diseases, as seen in its effects on cardio-metabolic outcomes, particularly in obesity, heart failure, and hypertension. In this review, we summarize the clinical evidence of the efficacy and safety of the KD in controlling risk factors for cardiovascular diseases and discuss the possible mechanisms of action based on recent evidence in understanding the influence of the KD at the cellular and molecular levels.
肥胖和心血管疾病是全球范围内的主要健康问题,减肥被用作一种治疗策略来改善各个方面。虽然有许多减肥方法,但最有效的方法之一是通过饮食方法。生酮饮食(KD)的特点是低碳水化合物、高脂肪和/或高蛋白,它被用于肥胖患者,因为它是一种很有前途的减肥治疗选择,也可以控制心血管疾病的风险因素,这在其对心脏代谢结果的影响中可以看到,尤其是在肥胖、心力衰竭和高血压方面。在这篇综述中,我们总结了 KD 控制心血管疾病风险因素的临床证据的有效性和安全性,并根据最近的证据讨论了可能的作用机制,以了解 KD 在细胞和分子水平上的影响。